Changes are afoot to meet higher caseloads amid rising demand, the survey of 6,830 cardiovascular providers suggests.

Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.

Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.

The data are largely in line with those seen at 5 years, but the follow-up reassures there’s no concern about valve ...

The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.

Having more-thorough workup uncovered an unexpected root cause and changed the treatment course for 76% of patients.

Researchers hoped the technique might involve lower exposure compared with right transradial access, but this didn’t pan out.

The real-world Evoque and new TRILUMINATE findings provide an “extension” from the pivotal trials, Dharam Kumbhani says.

The rate of death or HF hospitalization was not influenced by the presence of leads after accounting for comorbidity burden.

The device, which is delivered transapically, represents an option for very sick patients who previously have had none.

Modern is consistent with the literature in this space, but the trial shows that a staged complete procedure might be just ...